We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Innovative Laser System Facilitates Soft-Tissue Procedures

By HospiMedica International staff writers
Posted on 22 May 2013
An Er,Cr:YSGG (Erbium, Chromium doped: Yttrium Scandium Gallium Garnet) dental laser system can also serve as a surgical instrument for soft-tissue procedures in orthopedic and podiatric surgery.

The WaterLase iPlus is a dual wavelength laser system that delivers 2,780 nm  YSGG energy and 940 nm diode laser via the optional iLase wireless laser. More...
The system is intended for procedures that include debridement of both healthy and diseased tissue, soft tissue release, tendon transfer, incision, excision, coagulation and hemostasis, and nerve and vascular repair, in both in the upper and lower extremities. The system also cuts hard-tissue as fast as conventional drills, but without the discomfort or risk of cross contamination.

The Er,Cr:YSGG laser cuts tissues by energizing water molecules within the target and from the water sprayed on the tissue surface. From 5 to 100 pulses of YSGG laser energy are emitted each second from the tip of the hand piece along with the fine water spray. Laser photons energize the combined water molecules within the target tissue; when the energized water molecules vaporize, a biological and cool ablation of both hard and soft tissues occurs.

A graphical user interface controls dozens of preset laser-assisted clinical procedures, controlled via a "Point and Perform" interface that instantly programs the ideal settings for each procedure selected. The WaterLase iPlus is a product of Biolase (Irvine, CA, USA), and has been approved by the US Food and drug Administration (FDA) for incision, excision, resection, ablation, vaporization, coagulation and hemostasis, in orthopedic and podiatric surgery, including soft and cartilaginous tissue in small and large joints.

“During the past several years, the use of lasers in orthopedic surgery has become more accepted as a less invasive alternative to conventional surgery and it has become clear that modern lasers will play a significant role in the treatment of musculoskeletal injuries,” said Amado Carino, MD, global clinical affairs manager at Biolase. “The WaterLase iPlus will provide an innovative and relevant alternative to orthopedic and podiatric surgeons.”

Related Links:

Biolase


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
LED Surgical Lamp
ACEMST35/57
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.